Skip to content
Catalyst

magnesium(2+)Finding

Magnesium(2+) decreases Insomnia Severity Index (ISI) total score

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“Based on the intention-to-treat GLMM analysis detailed in Table 2, the magnesium bisglycinate group had a statistically significantly greater between-group mean reduction in ISI scores from baseline to Week 4 [−3.9 (95% CI, −5.8 to −2.0)] compared to the placebo group [−2.3 (95% CI, −4.1 to −0.4)] (p = 0.049).”
Quoted verbatim from Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial.
This finding among the 3 findings on its endpoint

magnesium(2+)

Insomnia Severity Index (ISI) total score

lowers

Who
Adults aged 18 to 65 years in good health reporting poor sleep for more than four weeks (RIS score above 12); intention-to-treat, GLMM-adjusted for baseline ISI, age, sex, BMI and occupation
Dose studied
magnesium bisglycinate, two capsules daily 30-60 minutes before bedtime, 250 mg elemental magnesium and 1523 mg glycine per day

Moderate evidencePMID 40918053 · 2025

02 · The study

Study
RCT
Duration
4 weeks

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7E57HGYW7XWW76740XMDJ7N